Unknown

Dataset Information

Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis.


ABSTRACT:

Unlabelled

The occurrence of malignant disease increases the risk for venous thromboembolism (VTE). Here we evaluate the risk for VTE in a large unselected cohort of patients with cancer receiving chemotherapy.

Methods

The United States IMPACT health care claims database was retrospectively analyzed to identify patients with a range of solid tumors who started chemotherapy from January 2005 through December 2008. International Classification of Diseases, 9th revision, Clinical Modification Codes were used to identify cancer location, presence of VTE 3.5 months and 12 months after starting chemotherapy, and incidence of major bleeding complications. Health care costs were assessed one year before initiation of chemotherapy and one year after initiation of chemotherapy.

Res

SUBMITTER: Lyman GH 

PROVIDER: S-EPMC3868427 | biostudies-literature | 2013

REPOSITORIES: biostudies-literature